Includes
- Essential thrombocythemia
- Polycythemia vera (PV)
- Primary myelofibrosis
Etiology
- 90% of patients have somatic phenotypic driver mutation in JAK2 (V617F), CALR or MPL
Clinical presentation
- Thromboembolism common when platelets 400-1000x10^9
- Cutaneous lesions: purpura, hematomas, livedo reticularis e racemosa, raynaud, urticaria, vasculite de pequenos vasos, úlceras de perna, gangrena, recurrent superficial trhombophlebitis
- Erythromelalgia: intense burning and paroxysmal bright erythema of the distal extremities
- Responds well to aspirin